← back to search

Feng Liu

Zhejiang University · CN
Area of research
Atomic and Molecular Physics, and Optics · Electrical and Electronic Engineering
Research interest
Research interests include Photonic and Optical Devices, Semiconductor Quantum Structures and Devices, Photonic Crystals and Applications, and Quantum and electron transport phenomena.
h-index
30
citations
3,470
works
149
NIH funding
primary concept
Materials science
email

Recent publications

Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
Annals of Oncology 2023cited by 73position: middledoi
Additional file 7 of Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity
Figshare 2023cited by 0position: firstdoi
Additional file 8 of Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity
Figshare 2023cited by 0position: firstdoi
Additional file 4 of Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity
Figshare 2023cited by 0position: firstdoi
Additional file 6 of Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity
Figshare 2023cited by 0position: firstdoi
Additional file 3 of Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity
Figshare 2023cited by 0position: firstdoi
Additional file 5 of Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity
Figshare 2023cited by 0position: firstdoi
Double-Pulse Generation of Indistinguishable Single Photons with Optically Controlled Polarization
Nano Letters 2022cited by 35position: lastdoi
Non-Invasive Preoperative Imaging Differential Diagnosis of Intracranial Hemangiopericytoma and Angiomatous Meningioma: A Novel Developed and Validated Multiparametric MRI-Based Clini-Radiomic Model
Frontiers in Oncology 2022cited by 16position: middledoi
Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models
Radiotherapy and Oncology 2016cited by 65position: firstdoi
Novel murine tumour models depend on strain and route of inoculation
International Journal of Experimental Pathology 2016cited by 10position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Song-lin Yin · Huazhong University of Science and Technology6 papers (2023–2023)Cheng Miao · Huazhong University of Science and Technology6 papers (2023–2023)Xiaoqian Chen · Ministry of Education of the People's Republic of China6 papers (2023–2023)Jiaxing Wu · Shihezi University6 papers (2023–2023)Qian Zhou · Kunming University of Science and Technology6 papers (2023–2023)Jingyi Peng · South China Agricultural University6 papers (2023–2023)Haifeng Jiang · Ministry of Education of the People's Republic of China6 papers (2023–2023)Xuan Cao · Huazhong University of Science and Technology6 papers (2023–2023)Tingting Zhang · Nantong University6 papers (2023–2023)Ximiao He · Center for Cancer Research6 papers (2023–2023)Xiaohong Xu · National University of Singapore6 papers (2023–2023)Panpan Gao · Huazhong University of Science and Technology6 papers (2023–2023)Xu Shijie · Guangzhou University of Chinese Medicine5 papers (2023–2023)Feng Pan · Fudan University3 papers (2023–2023) · 3 papers (2023–2023)Lingfang Wang · Nanchang University1 papers (2022–2022)Feng‐Ming Kong · Case Western Reserve University1 papers (2016–2016)Jiawang Yu · Zhejiang University1 papers (2022–2022)Zhen Wu · Fujian Medical University1 papers (2022–2022)Yuhua Wang · Nanjing University of Chinese Medicine1 papers (2016–2016)